Lanoptics LTD.
LNOP
Please see disclaimer at bottom of this document
November 7, 2005 Review of Form 6K earnings release for 9/30/05
1. Statement of Cash flows not yet filed. This makes analysis difficult, if not impossible.
2. Dilution seems heavy. Something always to watch
3. Inventory is building, as revenues are falling. Watch for potential write off.
4. Looks like burn is around $2.5M quarterly. If we use quarterly burn of $4.0M, there is still 5 quarters of cash. It is very possible that I over estimated the burn, but I want to be more conservative. Either way, cash could unarguably run out during fiscal 2007.
5. Balance Sheet Data
31-Dec-04 | 31-Mar-05 | 30-Jun-05 | 30-Sep-05 | |
Assets | ||||
Current Assets | ||||
Cash and Marketable Securities | $25,619 | $23,017 | $20,712 | $21,183 |
Trade Receivable Gross | $828 | $1,667 | $1,872 | $471 |
Less: Allowance | ($47) | ($47) | ($47) | $0 |
Other receivables and prepaid expense | $703 | $459 | $275 | $448 |
Inventories | $1,279 | $1,854 | $2,356 | $2,292 |
Total Current Assets | $28,382 | $26,950 | $25,168 | $24,394 |
Long Term Investments | ||||
Prepaid Development and Production | $476 | $455 | $430 | $397 |
Severance Pay Fund | $1,489 | $1,543 | $1,478 | $1,543 |
Total Long Term Investments | $1,965 | $1,998 | $1,908 | $1,940 |
Property and Equipment Net | $384 | $341 | $391 | $378 |
Intangible Assets, Net | $634 | $574 | $5,865 | $5,780 |
Total Assets | $31,365 | $29,863 | $33,332 | $32,492 |
Liabilites and Shareholders’ Equity | ||||
Current Liabilities | ||||
Trade Payables | $856 | $1,178 | $1,697 | $303 |
Other Payables and Accrued Expenses | $2,478 | $2,482 | $2,197 | $1,922 |
Total Current Liabilities | $3,334 | $3,660 | $3,894 | $2,225 |
Long Term Liabilities | ||||
Accrued Severance Pay | $1,985 | $2,034 | $1,922 | $1,983 |
Preferred Shares in Subsidiary | $35,937 | $36,144 | $35,185 | $38,463 |
Shareholders’ Deficiency | ||||
Share Capital | $70 | $70 | $75 | $75 |
Additional Paid In Capital | $53,193 | $53,231 | $61,196 | $61,185 |
Accumulated other Comprehensive Loss | ($84) | ($110) | ($73) | ($58) |
Accumulated Deficit | ($63,070) | ($65,166) | ($68,867) | ($71,381) |
Total Shareholders’ Deficiency | ($9,891) | ($11,975) | ($7,669) | ($10,179) |
Total Liabilites and Shareholders’ Equity | $31,365 | $29,863 | $33,332 | $32,492 |
September 29, 2005 Review of Form 6K earnings release for 6/30/05
1. Balance Sheet Data
30-Jun-05 | 31-Mar-05 | 31-Dec-04 | |
Assets | |||
Current Assets | |||
Cash and Marketable Securities | 20712 | 23017 | 25619 |
Trade Receivable Gross | 1872 | 1667 | 828 |
Less: Allowance | -47 | -47 | -47 |
Other receivables and prepaid expense | 275 | 459 | 703 |
Inventories | 2356 | 1854 | 1279 |
Total Current Assets | 25168 | 26950 | 28382 |
Long Term Investments | |||
Prepaid Development and Production | 430 | 455 | 476 |
Severance Pay Fund | 1478 | 1543 | 1489 |
Total Long Term Investments | 1908 | 1998 | 1965 |
Property and Equipment Net | 391 | 341 | 384 |
Intangible Assets, Net | 5865 | 574 | 634 |
Total Assets | 33332 | 29863 | 31365 |
Liabilities and Shareholders’ Equity | |||
Current Liabilities | |||
Trade Payables | 1697 | 1178 | 856 |
Other Payables and Accrued Expenses | 2197 | 2482 | 2478 |
Total Current Liabilities | 3894 | 3660 | 3334 |
Long Term Liabilities | |||
Accrued Severance Pay | 1922 | 2034 | 1985 |
Preferred Shares in Subsidiary | 35185 | 36144 | 35937 |
Shareholders’ Deficiency | |||
Share Capital | 75 | 70 | 70 |
Additional Paid In Capital | 61196 | 53231 | 53193 |
Accumulated other Comprehensive Loss | -73 | -110 | -84 |
Accumulated Deficit | -68867 | -65166 | -63070 |
Total Shareholders’ Deficiency | -7669 | -11975 | -9891 |
Total Liabilities and Shareholders’ Equity | 33332 | 29863 | 31365 |
Profit and Loss Statement
6 months ended | 3 months ended | 3 months ended | |
30-Jun-05 | 31-Mar-05 | 30-Jun-05 | |
Revenues | 3876 | 1873 | 2003 |
Cost of Revenues | 1488 | 739 | 749 |
Amortization of developed Technology | 120 | 60 | 60 |
Gross Profit | 2268 | 1074 | 1194 |
Operating Expenses: | |||
Research and Development | 4770 | 2086 | 2684 |
Write off of R&D | 1475 | 0 | 1475 |
Selling and Marketing | 1171 | 0 | 1171 |
General and Administrative | 745 | 1001 | -256 |
Total Operating Expenses | 8161 | 3087 | 5074 |
Operating Income (Loss) | -5893 | -2013 | -3880 |
Financial and Other Expenses | 110 | 88 | 22 |
Loss Before Minority Interest | -6003 | -2101 | -3902 |
Minority Interest in Sub | 206 | 5 | 201 |
Net Loss | -5797 | -2096 | -3701 |
Net Loss per share | ($0.54) | ($0.20) | ($0.35) |
Weighted Avg. Shares O/S | 10670815 | 10626285 | 44530 |
2. Some Analysis
a. Cash and marketable securities are $20,712 at June 30, 2005. They were $25,619 at 12/31/04 and 24,637 at 3/31/05.
b. Revenues increased QoQ by 6.94%
c. Receivables are getting high. I haven’t calculated DSO’s, but I imagine they are longer than typical. Lanoptics is in a lot of testing phases, hence I am concerned with the Receivables. The allowance of $47 also looks a bit meager.
d. Gross Profit % was 57.34% for 3 months ended 3/31/05 and 59.61% for 3 months ended 6/30/05.
e. Operating expenses went up QoQ by 64.37%.
f. Weighted average shares outstanding went up .42% for the quarter. That is an acceptable 1.6% run rate. Watch this closely.
g. Current Share Price is 6.50. Hence market cap is 69.360M. This is about 8X revenues.
h. Cash Flow adjustment. One can argue that write off of R&D is not recurring. I am keeping it here, unless I can be convinced otherwise.
6 months ended 30-Jun-05 |
|
Net Cash Used In Operating Activities | -4911 |
Less: Write-off of R&D | -1475 |
CapEx | -131 |
Adjusted Cash Used | -6517 |
i. EzChip ownership increased from 54.4% to 58.7% during the quarter. This was done via a swap of shares. I haven’t looked to closely.
j. If I ever get time, I will compare the 6 months ended from 2005 to 2004. This is identified in SEC filing. Revenues are up over $2,254 or 139%. Yet, operating expenses alone are up over $3,045.
k. NP-2 samples were shipped in July 2005.
l. Believes that working capital can sufficiently get them through the end of 2006. They could require more funds earlier, if they grow to rapidly or if sufficient revenue is not generated. I would like them to identify how much that “sufficient revenue” is.
Disclaimer
If you are a client of ours, and if you have questions regarding Lanoptics, please call our office. If you are not a client of Redfield, Blonsky & Co. LLC Investment Management Division and are reading these notes, we urge you to do your own research. We will not be responsible for any person making an investment decision based on these notes. these notes are a “by-product” of our research. We are not responsible for the accuracy of these notes. We are not responsible for errors that may occur in these notes. Please do not rely on us to monitor or update this or any other report we may issue. In theory, we could come across some type of data or idea, which causes us to eliminate our long position of Lanoptics from our portfolios. We will not notify readers revisions to these notes. We are not responsible to keep readers of these notes updated for changes or material errors or for any reason whatsoever. We manage portfolios for clients, and those clients are our greatest concern as it relates to investing. Certain clients of Redfield, Blonsky & Co LLC may not have eBay in their portfolios. There could be various reasons for this. Again, if you would like to discuss Lanoptics, please contact Ronald R. Redfield, CPA, PFS (partner in charge of investment management division).
Information herein is believed to be reliable, but its accuracy and completeness cannot be guaranteed. Opinions, estimates, and projections constitute our judgment and are subject to change without notice. This publication is provided to you for information purposes only and is not intended as an offer or solicitation. Redfield, Blonsky & Co. LLC and Ronald R Redfield, CPA, PFS, may hold a position or act as an advisor on any investments mentioned in a report or discussion.